Regulation · Australia

Are peptides legal
in Australia?

In Australia, BPC-157 and TB-500 are scheduled by name. Here is what the TGA, the Poisons Standard and the import rules say, with the 2026 enforcement record.

Short answerRegulation · 7 min read · Updated 17 Nov 2026

Not without authorisation. The TGA says “it is unlawful to import, advertise, manufacture and supply unapproved peptide products in Australia”. BPC-157 and TB-500 are Schedule 4 prescription-only medicines, and the Poisons Standard lists both among poisons that are illegal to possess without authority. A “research use only” label does not change this, the TGA says.

Key takeaways

  • The TGA says it is unlawful to import, advertise, manufacture and supply unapproved peptide products in Australia.
  • BPC-157 has been Schedule 4 (prescription only) since 1 June 2024; the October 2026 Poisons Standard also lists TB-500, thymosin beta-4, CJC-1295 and ipamorelin.
  • For BPC-157, TB-500 and several growth-hormone peptides, the Poisons Standard says possession without authority is illegal (Appendix D, clause 5).
  • The TGA says “research use only” disclaimers do not make supply lawful or permit importation.
  • In 2026 the TGA’s peptide actions included public warnings, seizures and infringement notices.

01What does the TGA say about unapproved peptides?

In August 2026 the TGA put the position in one sentence: “It is unlawful to import, advertise, manufacture and supply unapproved peptide products in Australia.” Under the Therapeutic Goods Act 1989, peptide products supplied for therapeutic use are regulated as therapeutic goods. Those not included on the Australian Register of Therapeutic Goods (ARTG) are “unapproved”.

The TGA’s April 2026 safety advisory names BPC-157, GHK-Cu, TB-500, retatrutide and CJC-1295 as examples of unapproved peptide products.

The TGA says penalties for breaching the Act include civil penalties of up to $1.82 million per breach for individuals or $18.2 million per breach for corporations, and criminal penalties of up to 7 years’ imprisonment.

Compounding is a narrow exception. The TGA says a compounded good is generally exempt from ARTG inclusion only where it is “dispensed or extemporaneously compounded for a particular person for application to that person”, or compounded in a hospital by a pharmacist for the hospital’s patients. Pharmacists and doctors who fall outside the exemptions in Schedule 8 of the Therapeutic Goods Regulations 1990 generally need a manufacturing licence, the TGA says.

02How does the Poisons Standard treat peptides? Schedule 4 and possession controls

The Poisons Standard decides how a substance may be supplied. Schedule 4 is “Prescription only medicines and prescription animal remedies”.

BPC-157 entered Schedule 4 on 1 June 2024. The TGA’s final decision, published on 22 May 2024, responded to “48 referrals for importation of BPC-157 received by the TGA since 1 July 2022” and aimed to “align the scheduling of BPC-157 with other performance- and image-enhancing substances”. The same decision added it to Appendix D, clause 5: “Poisons for which possession without authority is illegal”.

The current instrument, the Poisons Standard October 2026 (registered 30 September 2026), keeps those entries. Selected peptide entries:

SubstancePoisons Standard scheduleAppendix D, clause 5: possession without authority is illegal
BPC-157Schedule 4Yes
TB-500Schedule 4Yes
Thymosin beta-4Schedule 4Yes
CJC-1295Schedule 4Yes
IpamorelinSchedule 4Yes
Growth hormone releasing peptides (GHRPs), including GHRP-6Schedule 4Yes
Melanotan IISchedule 4No

Many peptides, including Semax, epitalon, MOTS-c and KPV, are not named individually. That does not make them lawful to sell: a product supplied for therapeutic use still needs ARTG inclusion, and group entries in the Standard may apply. We have not assessed each compound against the group entries.

The TGA notes that “state and territory laws may impose additional controls on the sale, supply and possession of unapproved peptide products.”

03How are peptide imports controlled in Australia?

Personal importation. The TGA’s April 2026 advisory says people importing unapproved peptides under the Personal Importation Scheme “must meet all other conditions of the Scheme, including having an appropriate medical authorisation or prescription when required”. Products identified only by codes, or that do not clearly state the active ingredient and strength, “cannot be assessed for lawful importation under the Personal Importation Scheme, and will not be considered for release”. In July 2026 the TGA said it is “increasingly intercepting unlabelled vials at the border”.

Customs permission for hormones. Under regulation 5G of the Customs (Prohibited Imports) Regulations 1956, substances in Schedule 7A may not be imported without written permission. Schedule 7A covers anabolic or androgenic substances, erythropoietin, darbepoetin alfa, gonadotrophins including HCG, and “natural and manufactured growth hormones, including somatropin, somatrem, somatomedins and insulin-like growth factors (not insulins) and growth hormone releasing hormones (somatorelin and synthetic analogues)”. A narrow exception for prescribed medicine carried by a ship or aircraft passenger does not apply to athletes or their support staff.

BPC-157 and TB-500 are not named in Schedule 7A. Their import is controlled through the therapeutic goods and poisons rules above.

04What did the TGA do about peptides in 2026?

In 2026 the TGA’s peptide actions included public warnings, seizures and infringement notices. From its own releases:

DateWhat the TGA did
13 Apr 2026Safety advisory on importing, compounding and supplying unapproved peptides: “research use only” disclaimers do not make supply lawful.
10 Jun 2026Added unapproved peptide products to its compliance priorities, citing a joint operation with Australian Border Force and Victoria Police that seized peptides, steroids and other products with an estimated street value above $2 million.
20 Jul 2026Put promoters and suppliers “on notice”. Manufacture, it said, includes “applying a label to a blank vial”.
17 Aug 2026Announced the seizure, with NSW Police, of more than $120,000 of peptide and steroid products allegedly linked to a social media influencer (warrants executed 4 Aug), including retatrutide, CJC-1295 and a combined BPC-157 and TB-500 product.
17 Aug 2026Safety advisory: TGA testing found inconsistent amounts of melanotan II in seized nasal sprays. It reported 27 infringement notices, totalling $101,412 and paid in May 2026, issued to a NSW individual for alleged unlawful supply.

The TGA has also said that “influencers, affiliates, online sellers and anyone else promoting unapproved peptide products may be held accountable for unlawful advertising”.

05Is BPC-157 prohibited in Australian sport?

Sport Integrity Australia describes BPC-157 as “an experimental peptide that is not approved for use by any regulatory agency worldwide”, and lists it under S0, non-approved substances, prohibited at all times. Under the customs rule above, athletes and their support staff cannot rely on the passenger exception for Schedule 7A hormones. Detail: peptides and anti-doping.

06What don’t we know about Australian peptide rules?

State and territory detail. How each jurisdiction enforces the Appendix D possession controls, and what penalties apply, is set by state and territory poisons laws we have not summarised here.

Unnamed peptides. Whether Semax, epitalon, MOTS-c, KPV or GHK-Cu fall under any group entry, or will be scheduled by name, is not something we can tell you from the Standard alone.

Changes are logged in our regulatory changelog. For the other markets, see the US, the UK or the overview.

This is a plain-English summary of public documents, checked on 17 Nov 2026. It is not legal advice.

RefSources

  1. TGA. TGA flexes its muscle against illegal peptides and steroids. Media release, 17 Aug 2026. www.tga.gov.au/news/media-releases/tga-flexes-its-muscle-aga…
  2. Therapeutic Goods (Poisons Standard—October 2026) Instrument 2026 (F2026L01327), Schedule 4 and Appendix D. Federal Register of Legislation, registered 30 Sep 2026. www.legislation.gov.au/F2026L01327/latest/text
  3. TGA. Notice of final decision to amend (or not amend) the current Poisons Standard: ACMS #43, ACCS #37, Joint ACMS-ACCS #35 (BPC-157). Scheduling decision, published 22 May 2024. www.tga.gov.au/resources/publication/scheduling-decisions-fi…
  4. Customs (Prohibited Imports) Regulations 1956, regulation 5G and Schedule 7A (compilation 147). Federal Register of Legislation, in force from 13 Jul 2026. www.legislation.gov.au/F1996B03651/latest/text
  5. TGA. Understanding your responsibilities when importing, compounding and supplying unapproved peptide products. Safety advisory, 13 Apr 2026. www.tga.gov.au/safety/safety-monitoring-and-information/safe…
  6. TGA. Unapproved peptide product promoters and suppliers are put on notice. Media release, 20 Jul 2026. www.tga.gov.au/news/media-releases/unapproved-peptide-produc…
  7. TGA. TGA strengthens compliance focus on unapproved peptide products as part of evolving risk response. Media release, 10 Jun 2026. www.tga.gov.au/news/media-releases/tga-strengthens-complianc…
  8. TGA. Melanotan II tanning peptide products found to be inconsistently dosed. Safety advisory, 17 Aug 2026. www.tga.gov.au/safety/safety-monitoring-and-information/safe…
  9. Sport Integrity Australia. BPC-157 information. Substance education page. www.sportintegrity.gov.au/what-we-do/anti-doping/substance-e…

Plain-English summary of public sources, not legal or medical advice. Last checked 17 Nov 2026.

Questions

Is BPC-157 legal in Australia?

It is a Schedule 4 prescription-only medicine, and the Poisons Standard lists it among poisons that are illegal to possess without authority. It is not approved by the TGA, so supplying it is unlawful unless an exemption applies.

What does the TGA say about importing unapproved peptides?

The TGA says “research use only” disclaimers do not permit importation, that products identified only by codes will not be considered for release under the Personal Importation Scheme, and that it is increasingly intercepting unlabelled vials at the border. BPC-157 and TB-500 are also illegal to possess without authority.

What penalties apply for selling unapproved peptides?

The TGA says breaches of the Therapeutic Goods Act can attract civil penalties of up to $1.82 million per breach for individuals and $18.2 million for corporations, and criminal penalties of up to 7 years’ imprisonment. It also issues infringement notices and seizes products.

Can a pharmacist compound peptides in Australia?

A compounded product is generally exempt from ARTG inclusion only when made for a particular person, or in a hospital for its patients. Schedule 4 peptides also need a prescription, and the TGA expects compounders to meet all Commonwealth and state requirements.

Does the US HHS policy apply in Australia?

No. It is a US enforcement policy. Australian supply is governed by the Therapeutic Goods Act, the Poisons Standard and state and territory law.

Evidence before hype.

One email a week: new research explained and regulatory changes. No prices, no hype.

Get the 6:00 brief

Free. Unsubscribe any time.

Written by 6AM Research. Drafted from primary sources; every claim links to its source, and the page is dated. Editorial policy · How we check every page
Every batch has a public lab report. Look it up by the batch number on the vial. Batch COA lookup